Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (151-160 of 380) with videos related to

Pageof 38
Sort By:
Haematologica|January 1, 1972
[Urinary iron after desferrioxamine. I. Effectiveness and tolerance of high doses of the drug]G Cartei, M Cazzavillan, T Chisesi, et al.
Lancet (London, England)|June 6, 1992
Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyT Barbui, A Rambaldi, L Parenzan, et al.
Thrombosis and Haemostasis|June 12, 1999
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profileM Galli, G Finazzi, F Norbis, et al.
Thrombosis and Haemostasis|December 1, 1994
Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulationG Finazzi, A Falanga, M Galli, et al.
Minerva Medica|March 17, 1978
[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease]G Cartei, M Cazzavillan, T Chisesi, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Increased production of mononuclear cell procoagulant activity in Hodgkin's diseaseP Viero, S Cortellazzo, C Casarotto, et al.
British Journal of Haematology|November 1, 1984
Pure white cell aplasia treated by high dose intravenous immunoglobulinT Barbui, R Bassan, P Viero, et al.
Minerva Medica|July 28, 1975
[Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside]E Dini, T Barbui, G Cartei, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and functionT Barbui, S Cortelazzo, P Viero, et al.
European Journal of Epidemiology|July 1, 1993
Nosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patientsA Grigis, A Goglio, M Parea, et al.
Pageof 38

Showing results (151-160 of 380) with videos related to

Sort By:
Pageof 38
Haematologica|January 1, 1972
[Urinary iron after desferrioxamine. I. Effectiveness and tolerance of high doses of the drug]G Cartei, M Cazzavillan, T Chisesi, et al.
Lancet (London, England)|June 6, 1992
Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyT Barbui, A Rambaldi, L Parenzan, et al.
Thrombosis and Haemostasis|June 12, 1999
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profileM Galli, G Finazzi, F Norbis, et al.
Thrombosis and Haemostasis|December 1, 1994
Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulationG Finazzi, A Falanga, M Galli, et al.
Minerva Medica|March 17, 1978
[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease]G Cartei, M Cazzavillan, T Chisesi, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Increased production of mononuclear cell procoagulant activity in Hodgkin's diseaseP Viero, S Cortellazzo, C Casarotto, et al.
British Journal of Haematology|November 1, 1984
Pure white cell aplasia treated by high dose intravenous immunoglobulinT Barbui, R Bassan, P Viero, et al.
Minerva Medica|July 28, 1975
[Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside]E Dini, T Barbui, G Cartei, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and functionT Barbui, S Cortelazzo, P Viero, et al.
European Journal of Epidemiology|July 1, 1993
Nosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patientsA Grigis, A Goglio, M Parea, et al.
Pageof 38